Suppr超能文献

[分化型甲状腺癌的治疗。前瞻性研究]

[Therapy of differentiated thyroid carcinomas. Prospective study].

作者信息

Gemsenjäger E, Staub J J, Heitz P U

出版信息

Schweiz Med Wochenschr. 1985 Feb 2;115(5):153-9.

PMID:3975583
Abstract

UNLABELLED

During an 11-year period (1973-1984) a consecutive series of papillary (n = 30) and follicular (n = 38) thyroid carcinomas was prospectively selected, on the basis of a clinico-pathologic and prognostic classification, for 1) non-total thyroidectomy (n = 20), 2) total thyroidectomy (n = 13), or 3) total thyroidectomy and radioiodine (n = 35), together with exogenous suppressive thyroxine therapy in most patients. Patients with an occult papillary carcinoma and patients under 40-50 years of age with an intrathyroidal, single papillary carcinoma without nodes, and microangioinvasive follicular carcinoma were often treated by non-total thyroidectomy or without radioiodine. Some patients refused adequately radical therapy (completion of thyroidectomy or radioiodine).

RESULTS

a half-year to 11 (5 +/- 3) years following treatment no recurrences or deaths occurred in occult papillary and in microangioinvasive follicular tumors (treated by total thyroidectomy and radioiodine in 1 of 9 and in 2 of 9 patients respectively); 1 death and 1 curable recurrence occurred in the intrathyroidal papillary carcinoma group (treated by total thyroidectomy and radioiodine in 7 of the 15 patients); 3 patients died and there were 4 recurrences (3 locoregional, 1 systemic) in the patients suffering from extrathyroidal papillary or angioinvasive follicular carcinoma (treated by total thyroidectomy and radioiodine in all of the 6 and in 19 of 29 patients respectively). Patients who died (all had pulmonary metastases at the time of diagnosis) and those with a recurrence had total thyroidectomy with radioiodine as the primary treatment. In lethal papillary carcinomas, large follicular and solid areas, squamous cell metaplasia or anaplastic transformation were observed.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

未标注

在11年期间(1973 - 1984年),根据临床病理和预后分类,前瞻性地选取了一系列连续的乳头状癌(n = 30)和滤泡状癌(n = 38)患者,分别进行:1)非全甲状腺切除术(n = 20);2)全甲状腺切除术(n = 13);或3)全甲状腺切除术加放射性碘治疗(n = 35),大多数患者同时接受外源性甲状腺素抑制治疗。隐匿性乳头状癌患者以及40 - 50岁以下、甲状腺内单发乳头状癌且无淋巴结转移、微侵袭性滤泡状癌患者常采用非全甲状腺切除术或不进行放射性碘治疗。部分患者拒绝充分的根治性治疗(完成甲状腺切除术或放射性碘治疗)。

结果

治疗后半年至11(5 ± 3)年,隐匿性乳头状癌和微侵袭性滤泡状肿瘤(分别有9例中的1例和9例中的2例接受全甲状腺切除术加放射性碘治疗)未出现复发或死亡;甲状腺内乳头状癌组出现1例死亡和1例可治愈的复发(15例患者中有7例接受全甲状腺切除术加放射性碘治疗);甲状腺外乳头状癌或侵袭性血管滤泡状癌患者中有3例死亡,4例复发(3例局部复发,1例全身复发)(分别有6例中的全部和29例中的19例接受全甲状腺切除术加放射性碘治疗)。死亡患者(均在诊断时已有肺转移)和复发患者最初接受的治疗为全甲状腺切除术加放射性碘治疗。在致死性乳头状癌中,观察到大片滤泡状和实性区域、鳞状上皮化生或间变。(摘要截断于250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验